Blue Jet Healthcare Share Price Target 2026 Analyst Forecast Bull and Bear Case

The Blue Jet Healthcare share price target 2026 is Rs 555, based on analyst estimates and the FY27 earnings recovery thesis for Blue Jet Healthcare (NSE: BLUEJET). Q4 FY26 results announced May 30, 2026 are the immediate re-rating trigger. This article covers the complete Blue Jet Healthcare share price target analysis including sector tailwinds, peer context, key risks, and the bull and bear case scenarios updated May 30, 2026.

Click Here – Get Free Investment Predictions

Blue Jet Healthcare Share Price Target 2026: Key Takeaways

• Blue Jet Healthcare share price target 2026: Rs 555 (base case, 20% upside from CMP Rs 460.85)
• Bull case target: Rs 670 | Bear case target: Rs 370
• NSE ticker: BLUEJET | Sector: Pharmaceutical Contrast Media and APIs | Market cap: Rs 4,609 crore
• 52 week range: Rs 306 to Rs 713 | Trailing PE: 28x
• Key catalyst: Q4 FY26 results (May 30, 2026) confirming FY27 earnings recovery
• Key risk: FY27 earnings miss or sustained FII outflows from Indian equities

Blue Jet Healthcare Company Overview

Blue Jet Healthcare (NSE: BLUEJET) is a Mumbai-based manufacturer of contrast media intermediates, pharmaceutical APIs, and specialty chemicals supplying to global imaging agent manufacturers including GE Healthcare and Bayer, listed November 2023, with FY26 revenue of Rs 830 crore. At CMP Rs 460.85 against a 52 week range of Rs 306 to Rs 713, the stock trades at a discount to its 52 week high. Market capitalisation stands at Rs 4,609 crore with a trailing PE of 28x. Compared to peers in specialty pharma like Divi’s Laboratories and Fine Organics, Blue Jet Healthcare is positioned as a potential re-rating candidate toward the Blue Jet Healthcare share price target of Rs 555 on FY27 earnings delivery.

Parameter	Value
NSE Ticker	BLUEJET
Sector	Pharmaceutical Contrast Media and APIs
CMP (May 30, 2026)	Rs 460.85
52 Week High	Rs 713
52 Week Low	Rs 306
Market Cap	Rs 4,609 crore
Trailing PE	28x
12-Month Analyst Target	Rs 555
Bull Case Target	Rs 670
Bear Case Target	Rs 370

Why Is the Blue Jet Healthcare Share Price Target Set at Rs 555 for 2026

FY27 Earnings Delivery and Revenue Acceleration

The Blue Jet Healthcare share price target 2026 of Rs 555 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results confirming the earnings recovery trajectory are the most direct catalyst for re-rating from CMP Rs 460.85 toward Rs 555.

Structural Sector Tailwinds in Pharmaceutical Contrast Media and APIs

The Pharmaceutical Contrast Media and APIs sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising corporate investment. Blue Jet Healthcare’s market position among peers in specialty pharma like Divi’s Laboratories and Fine Organics creates a structural growth runway supporting the Blue Jet Healthcare share price target consensus of Rs 555 and the bull case of Rs 670.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle, which began in early 2026, reduces Blue Jet Healthcare’s borrowing costs and stimulates demand across end markets. Lower interest costs improve EPS trajectory, directly supporting the Blue Jet Healthcare share price target 2026 of Rs 555.

Union Budget 2026-27 Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Blue Jet Healthcare’s Pharmaceutical Contrast Media and APIs operations, improving the probability of achieving the Blue Jet Healthcare share price target of Rs 555.

Improving FII Flows Post the April 2026 Tariff Shock

As global macro conditions normalise post the April 2026 US tariff event, FII flows into quality Indian equities are recovering. At 28x PE, Blue Jet Healthcare is positioned as a beneficiary of institutional reallocation supporting the path to the Blue Jet Healthcare share price target of Rs 555.

Blue Jet Healthcare Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Blue Jet Healthcare Share Price Target: 3 to 6 Months

The near-term Blue Jet Healthcare share price target is anchored to support near the 52 week low of Rs 306. A confirmed Q4 FY26 earnings recovery serves as the trigger for an initial 10 to 15 percent re-rating toward the 12-month target of Rs 555.

12-Month Blue Jet Healthcare Share Price Target 2026

The 12-month Blue Jet Healthcare share price target 2026 is Rs 555, implying approximately 20 percent upside from CMP Rs 460.85. This base case assumes in-line FY27 earnings delivery and partial FII flow normalisation. Track live on NSE ticker BLUEJET.

Long Term Blue Jet Healthcare Share Price Target: FY27 to FY28

For investors with a 2 to 3 year horizon, the long-term Blue Jet Healthcare share price target is Rs 670 in the bull case, assuming full earnings delivery through FY27 to FY28 and sector re-rating among peers in specialty pharma like Divi’s Laboratories and Fine Organics.

Bull Case and Bear Case for the Blue Jet Healthcare Share Price Target

Bull Case Blue Jet Healthcare Share Price Target: Rs 670

The bull case for the Blue Jet Healthcare share price target of Rs 670 materialises when FY27 earnings beat estimates, sector tailwinds accelerate beyond consensus, and FII flows return strongly. The stock re-rates toward higher multiples, making Rs 670 achievable within FY28.

Bear Case Blue Jet Healthcare Share Price Target: Rs 370

The bear case sees the Blue Jet Healthcare share price target testing Rs 370 if FY27 earnings disappoint and FII outflows persist. At Rs 370, the stock approaches the 52 week low of Rs 306, requiring a full reassessment of the investment thesis.

Scenario	Target	Key Conditions
Bull Case	Rs 670	FY27 earnings beat, re-rating, strong FII inflows
Base Case	Rs 555	In-line FY27 delivery, partial FII recovery
Bear Case	Rs 370	FY27 earnings miss, guidance cut, FII outflows

Key Risks to the Blue Jet Healthcare Share Price Target 2026

US Tariff and Global Macro Risk

The 26 percent US reciprocal tariff announced April 2, 2026 triggered FII outflows across Indian equities. Prolonged trade tension remains the most prominent macro risk to the Blue Jet Healthcare share price target 2026 of Rs 555.

Valuation and Earnings Miss Risk

Any FY27 earnings miss or guidance cut could trigger multiple compression, posing a direct risk to the Blue Jet Healthcare share price target of Rs 555. Monitoring quarterly results closely is essential for investors tracking Blue Jet Healthcare.

Competitive Pressure in Pharmaceutical Contrast Media and APIs

Intensifying competition among peers in specialty pharma like Divi’s Laboratories and Fine Organics could compress Blue Jet Healthcare’s pricing power and market share over the medium term, which must be factored into any assessment of the Blue Jet Healthcare share price target of Rs 555.

FII Selling Pressure and Liquidity Risk

Sustained FII outflows from Indian equities can delay re-rating toward the Blue Jet Healthcare share price target of Rs 555 regardless of company-level improvement through FY27.

How to Invest in Blue Jet Healthcare

Check the Univest Screener for live data

Begin by reviewing Blue Jet Healthcare’s Q4 FY26 results, annual report, and FY27 guidance before forming a view on the Blue Jet Healthcare share price target of Rs 555. Focus on revenue growth trajectory, margin trends, and management commentary on Pharmaceutical Contrast Media and APIs sector opportunities and headwinds.

Open a Demat and trading account with a SEBI registered stockbroker to buy Blue Jet Healthcare (NSE: BLUEJET) with full regulatory protection. Understand the competitive dynamics among peers in specialty pharma like Divi’s Laboratories and Fine Organics before executing any position in Blue Jet Healthcare.

Plan your entry near the 52 week low support of Rs 306. A confirmed Q4 FY26 earnings uptick and positive FY27 guidance would strengthen the entry case for the Blue Jet Healthcare share price target of Rs 555. Set a disciplined stop loss below the 52 week low.

Restrict any single stock to 3 to 5 percent of your total equity portfolio to manage concentration risk, especially in the Pharmaceutical Contrast Media and APIs space where sectoral cycles can amplify volatility beyond comfort levels.

Always consult a SEBI registered financial advisor before investing based on any Blue Jet Healthcare share price target estimate. A registered advisor personalises recommendations based on your risk profile and financial goals. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track Blue Jet Healthcare’s live price and get daily stock recommendations.

FAQs on Blue Jet Healthcare Share Price Target 2026

What is the Blue Jet Healthcare share price target for 2026?

Ans. The Blue Jet Healthcare share price target 2026 is Rs 555, implying approximately 20 percent upside from the current market price of Rs 460.85. The bull case target is Rs 670 and the bear case is Rs 370, based on FY27 earnings estimates.

What is the Blue Jet Healthcare share price target for 2025?

Ans. The Blue Jet Healthcare share price target for 2025 was based on FY26 earnings expectations. The current 2026 analyst consensus target is Rs 555, reflecting FY27 growth projections and sector re-rating potential from CMP Rs 460.85.

Is Blue Jet Healthcare a good buy at Rs 460.85?

Ans. At Rs 460.85, Blue Jet Healthcare offers potential upside to the share price target of Rs 555 if FY27 earnings recover as projected. Investment suitability depends on individual risk tolerance and portfolio goals. Consult a SEBI registered financial advisor before investing.

What is the 52 week high and low of Blue Jet Healthcare?

Ans. The 52 week high of Blue Jet Healthcare is Rs 713 and the 52 week low is Rs 306. At CMP Rs 460.85, the stock trades at a discount to its 52 week high, creating upside potential toward the 12-month share price target of Rs 555.

What are the key risks to the Blue Jet Healthcare share price target?

Ans. Key risks to the Blue Jet Healthcare share price target of Rs 555 include an FY27 earnings miss, US tariff-driven FII outflows from Indian equities, competitive pressure in the Pharmaceutical Contrast Media and APIs sector, and global demand slowdown. Monitoring quarterly results is essential.

What are the catalysts for the Blue Jet Healthcare share price target?

Ans. Primary catalysts for the Blue Jet Healthcare share price target of Rs 555 include FY27 PAT recovery, structural tailwinds in Pharmaceutical Contrast Media and APIs, RBI rate cut support reducing cost of capital, Union Budget 2026-27 policy uplift, and FII flow normalisation into Indian equities.

How does Blue Jet Healthcare compare to its peers?

Ans. Blue Jet Healthcare operates in the Pharmaceutical Contrast Media and APIs sector alongside peers in specialty pharma like Divi’s Laboratories and Fine Organics. At CMP Rs 460.85 with a market cap of Rs 4,609 crore, the company is positioned within its peer group as a potential re-rating candidate toward the share price target of Rs 555 on FY27 earnings delivery.

What is the Blue Jet Healthcare share price target for 2027?

Ans. The long-term Blue Jet Healthcare share price target for FY27 to FY28 is Rs 670 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows into Indian equities. Consult a SEBI registered financial advisor for personalised guidance.